Affordable Access

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.

Authors
  • 1
Type
Published Article
Journal
Journal of Clinical Oncology
0732-183X
Publisher
American Society of Clinical Oncology
Publication Date
Volume
11
Issue
8
Pages
1482–1488
Identifiers
PMID: 8101562
Source
Medline

Abstract

Myeloblative therapy with hyper-ME +/- C radiochemotherapy can improve the prognosis of multifocal primary and early or multiple relapsing Ewing's sarcoma.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F